No evidence of substantial growth progression or complications of large focal nodular hyperplasia during pregnancy

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 1, 2013, Pages 88-92

  Rifai, Kinan ^a   Mix, Heiko ^a   Krusche, Susanne ^a   Potthoff, Andrej ^a   Manns, Michael P ^a   Gebel, Michael J ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Focal nodular hyperplasia; Liver tumor; Oral contraception; Pregnancy; Ultrasound

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; FEAR; FEMALE; HUMAN; NODULAR HYPERPLASIA; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; TUMOR VOLUME; ULTRASOUND;

ADULT; COHORT STUDIES; CONTRACEPTIVES, ORAL; DISEASE PROGRESSION; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCTIVE HISTORY; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84871377329     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.737361     Document Type: Article

References (15)

1. Lizardi-Cervera J, Cuéllar-Gamboa L, Motola-Kuba D. Focal nodular hyperplasia and hepatic adenoma: A review. Ann Hepatol 2006;5:206-11. (Pubitemid 44435365)
2. Kim TK, Jang HJ, Burns PN, Murphy-Lavallee J, Wilson SR. Focal nodular hyperplasia and hepatic adenoma: Differentiation with low-mechanical-index contrast-enhanced sonography. Am J Roentgenol 2008;190:58-66.
3. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D, et al. Benign and solid tumors of the liver: Relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67:173-8. (Pubitemid 33738212)
4. Heinemann LA, Weimann A, Gerken G, Thiel C, Schlaud M, DoMinh T. Modern oral contraceptive use and benign liver tumors: The German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 1998;3:194-200. (Pubitemid 128690547)
5. Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000; 118:560-4. (Pubitemid 30140854)
6. Scalori A, Tavani A, Gallus S, La Vecchia C, Colombo M. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: A case-control study. Am J Obstet Gynecol 2002; 186:195-7. (Pubitemid 34165432)
7. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann NY Acad Sci 2006;1089:228-36. (Pubitemid 47092098)
8. Perarnau JM, Bacq Y. Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy. Semin Liver Dis 2008;28:315-27.
9. Kapp N, Curtis KM. Hormonal contraceptive use among women with liver tumors: A systematic review. Contraception 2009;80:387-90.
10. Scott LD, Katz AR, Duke JH, Cowan DF, Maklad NF. Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver. JAMA 1984;251:1461-3. (Pubitemid 14161426)
11. Weimann A, Mössinger M, Fronhoff K, Nadalin S, Raab R. Pregnancy in women with observed focal nodular hyperplasia of the liver. Lancet 1998;351:1251-2. (Pubitemid 28181971)
12. Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004;187:181-91. (Pubitemid 38183430)
13. Byrnes V, Cárdenas A, Afdhal N, Hanto D. Symptomatic focal nodular hyperplasia during pregnancy: A case report. Ann Hepatol 2004;3:35-7.
14. Kuo YH, Wang JH, Lu SN, Hung CH, Wei YC, Hu TH, et al. Natural course of hepatic focal nodular hyperplasia: A long-term follow-up study with sonography. J Clin Ultrasound 2009;37:132-7.
15. Noels JE, van Aalten SM, van der Windt DJ, Kok NF, de Man RA, Terkivatan T, et al. Management of hepatocellular adenoma during pregnancy. J Hepatol 2011;54:553-8.